[Angiotensin II receptor subtype in human adrenal glands]

Area of Science:

• Endocrinology
• Molecular Biology
• Renal Physiology

Background:

• The adrenal gland is a key target for angiotensin II (Ang II).
• The specific roles of Ang II receptor subtypes in adrenal function remain largely unelucidated.
• Understanding these roles is crucial for adrenal pathophysiology.

Purpose of the Study:

• To investigate the expression and function of Ang II receptor subtypes (AT1 and AT2) in human adrenal tissues.
• To determine the involvement of AT1 and AT2 receptors in Ang II-stimulated aldosterone secretion.

Main Methods:

• Reverse transcription-polymerase chain reaction (RT-PCR) with Southern blot analysis to detect AT1 and AT2 mRNA expression in various human adrenal tissues.
• In vitro experiments measuring aldosterone secretion in response to Ang II, AT1 antagonist (CV-11974), and AT2 agonist (CGP-42112).
• Studies using AT1a knockout mice to assess Ang II's effect on aldosterone secretion.

Main Results:

• Both AT1 and AT2 receptor mRNAs were detected in normal adrenal tissues, aldosterone-producing adenoma, Cushing's syndrome, and pheochromocytoma.
• Ang II-induced aldosterone secretion was only partially (50%) suppressed by an AT1 antagonist, while an AT2 agonist significantly increased secretion (55%).
• Ang II and the AT2 agonist did not influence cortisol secretion; Ang II stimulated aldosterone in AT1a knockout mice.

Conclusions:

• Both AT1 and non-AT1 receptor subtypes, including AT2, are involved in stimulating aldosterone secretion from human adrenal glands.
• The findings suggest a more complex regulatory mechanism for aldosterone secretion than previously understood, involving multiple Ang II receptor pathways.
• These results have implications for understanding and potentially treating conditions involving aldosterone dysregulation.